Related Experiment Video
Updated: Aug 17, 2025

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
Acute Kidney Injury Among Patients with Multi-Drug Resistant Infection: A Study from Jordan
Ashraf O Oweis1, Heba N Zeyad1, Sameeha A Alshelleh2
1Department of Internal Medicine, Nephrology Division, Jordan University of Science and Technology, Irbid, Jordan.
Background:
Acute kidney injury (AKI) is a well-known complication for hospitalized patients. Sepsis and various infections play a significant role in increasing the incidence of AKI. The present study evaluated the risk for Multidrug-resistant (MDR) infections and its effect on the incidence of AKI, hospitalization, need for dialysis, and mortality.
Methods:
In a retrospective study design, data were collected from all adult patients with a positive multi-drug resistant culture who were admitted to King Abdullah University Hospital (KAUH). Records of 436 patients were reviewed between January 2017 - December 2018 with at least one year of follow-up.
Results:
The mean age was 57.3 years (SD± 23.1), and 58.5% were males. The most common source of positive cultures was sputum, with 50% positive cultures. The incidence of AKI was 59.2%. The most isolated microorganism was Acinetobacter baumannii (76.8%), followed by Pseudomonas aeruginosa (14.9%).On multivariate analysis, age (OR 1.1, 95% CI 1.1-1.2, P=0.001), HTN (OR 1.8, 95% CI 1.0-3.3, P=0.02), DM (OR 1.1, 95% CI 0.6-1.9, P=0.69) and the use of Foley catheter on chronic bases (OR 4.3, 95% CI 2.6-6.8, P<0.0001) were strong predictors of AKI. Among patients with AKI, 74.4% died compared to 44.4% among non-AKI patients (p<0.001).
Conclusion:
In patients with MDR, AKI incidence, hospitalization, and mortality were high. Early detection and addressing the problem may decrease bad outcomes, and health education for reducing antibiotic abuse is needed to lower MDR.
Insights
Multidrug-resistant (MDR) infections significantly increase the risk of acute kidney injury (AKI) in hospitalized patients, leading to higher rates of hospitalization and mortality. Early detection and intervention are crucial to improve outcomes and reduce the burden of MDR infections.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Acute kidney injury (AKI) is a common complication in hospitalized patients, often associated with sepsis and infections.
- Multidrug-resistant (MDR) infections represent a growing threat, potentially exacerbating AKI incidence and patient outcomes.
Purpose of the Study:
- To evaluate the association between multidrug-resistant (MDR) infections and the incidence of acute kidney injury (AKI).
- To assess the impact of MDR infections on hospitalization duration, need for dialysis, and mortality rates in patients with AKI.
Main Methods:
- Retrospective study design analyzing data from adult patients with positive MDR cultures admitted to King Abdullah University Hospital (KAUH).
- Review of medical records for 436 patients between January 2017 and December 2018, with at least one year of follow-up.
Main Results:
- The incidence of AKI was 59.2% among patients with MDR infections. Key predictors of AKI included advanced age, hypertension, and chronic Foley catheter use.
- Mortality rates were substantially higher in patients with AKI (74.4%) compared to those without AKI (44.4%).
- Acinetobacter baumannii and Pseudomonas aeruginosa were the most frequently isolated MDR microorganisms.
Conclusions:
- MDR infections are linked to high rates of AKI, prolonged hospitalization, and increased mortality.
- Early detection and management of MDR infections are essential to mitigate adverse outcomes.
- Public health initiatives promoting judicious antibiotic use are necessary to combat the rise of MDR infections.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury III: Clinical Manifestations
Acute Pyelonephritis II: Diagnostic Studies and Management

